NIT Rourkela develops novel bio-ink for 3D bioprinting and tissue engineering

The innovation is particularly suited for bone and cartilage repair

Eli Lilly flags counterfeit Mounjaro seizure in Gurugram

The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

SRM International Hand Conclave 2026 spotlights innovation and collaboration in hand rehabilitation

The conclave brought together over 1,000 delegates from across India and internationally

Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO

Move to accelerate cancer care expansion across India

Rusan Pharma secures Japan PMDA GMP approval for API, FDF facilities

PMDA is regarded among the most stringent regulatory bodies globally

AWS unveils Amazon Bio Discovery to accelerate drug design with AI

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe

Marengo Asia Hospitals acquires majority stake in Sunshine Global Hospitals

Move strengthens footprint in Western India and expands multi-specialty care network